Skip to main content
. 2022 Jun 28;12:880459. doi: 10.3389/fonc.2022.880459

Figure 5.

Figure 5

Principal component analysis and comparison of FRL prognostic signature with different prognostic signatures and clinical features. (A) Principal component analysis in the TARGET cohort. (B) Comparison of various lncRNA prognostic signatures in the TARGET cohort. (C) Comparison of FRL prognostic signature with different clinical features. (D) Expression heatmap of the five ferroptosis-related lncRNAs.